T1 mapping in cardiac amyloidosis: Can we get there from here?

JACC: Cardiovascular Imaging

Volumn 6, Issue 4, 2013, Pages 498-500

  Ruberg, Frederick L ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

amyloidosis; cardiac magnetic resonance imaging; T1 mapping

Indexed keywords

AMYLOID; GADOLINIUM;

AORTA STENOSIS; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FIBROSING ALVEOLITIS; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LIGHT CHAIN; NOTE; PARTITION COEFFICIENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; WILD TYPE;

EID: 84876152459     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2013.01.007     Document Type: Editorial

References (17)

1. S.W. Dubrey, K. Cha, J. Anderson The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement Q J Med 91 1998 141 157
2. H.K. Meier-Ewert, V. Sanchorawala, J.L. Berk, F.L. Ruberg Cardiac amyloidosis: evolving approach to diagnosis and management Curr Treat Options Cardiovasc Med 13 2011 528 542
3. P. Pellikka, D. Holmes, W. Edwards, R. Nishimura, A. Tajik, R. Kyle Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement Arch Intern Med 148 1988 662 666
4. R.H. Falk Diagnosis and management of the cardiac amyloidoses Circulation 112 2005 2047 2060
5. A.M. Maceira, J. Joshi, S.K. Prasad Cardiovascular magnetic resonance in cardiac amyloidosis Circulation 111 2005 186 193
6. H. Vogelsberg, H. Mahrholdt, C.C. Deluigi Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy J Am Coll Cardiol 51 2008 1022 1030
7. I.S. Syed, J.F. Glockner, D. Feng Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis J Am Coll Cardiol Img 3 2010 155 164
8. F.L. Ruberg, E. Appelbaum, R. Davidoff Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis Am J Cardiol 103 2009 544 549
9. B.A. Austin, W.H. Tang, E.R. Rodriguez Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis J Am Coll Cardiol Img 2 2009 1369 1377
10. T.D. Karamitsos, S.K. Piechnik, S.M. Banypersad Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis J Am Coll Cardiol Img 6 2013 488 497
11. A. Maceira, S. Prasad, P. Hawkins, M. Roughton, D. Pennell Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis J Cardiovasc Magn Reson 10 2008 54 66
12. W. Hosch, M. Bock, M. Libicher MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis Invest Radiol 42 2007 636 642
13. M.A. Gertz Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management Am J Hematol 86 2011 180 186
14. F.P. Mongeon, M. Jerosch-Herold, O.R. Coelho-Filho, R. Blankstein, R.H. Falk, R.Y. Kwong Quantification of extracellular matrix expansion by CMR in infiltrative heart disease J Am Coll Cardiol Img 5 2012 897 907
15. C. Rapezzi, G. Merlini, C.C. Quarta Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types Circulation 120 2009 1203 1212
16. S. Dass, J.J. Suttie, S.K. Piechnik Myocardial tissue characterization using magnetic resonance noncontrast T1 mapping in hypertrophic and dilated cardiomyopathy Circ Cardiovasc Imaging 5 2012 726 733
17. S.K. Piechnik, V.M. Ferreira, E. Dall' Armellina Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold J Cardiovasc Magn Reson 12 2010 69